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Isomaltohexaose (IM6) 1 is a  six-sugar hapten whose structure is homologous with 
antigenic determinants in a(1--~6)-linked dextrans, such as B512 dextran (Dex). IM6- 
keyhole limpet hemocyanin (KLH) conjugates induce thymus-dependent  (TD) anti- 
body responses in adult  mice in which almost all the anti-hapten antibody binds to 
Dex  (1,  2).  Thus,  IM6-KLH can  be used  as  a  TD  antigenic  analogue  of Dex  to 
examine the immune responsiveness of neonatal mice and of mice expressing the xid 
determined  immune defect  (xid mice) to Dex and to other polysaccharide antigens. 
These soluble polysaccharides and their hapten derivatives are members of a class of 
antigens which we have designated as type 2 antigens  (3,  4)  (Mond, J. J., j. Ferrar, 
W. E. Paul, M. Schaefer, and M. Howard, manuscript in preparation). 
xid mice lack the subset of B lymphocytes characterized by the Lyb-3 (5) and Lyb- 
5  (6) cell surface markers. These cells (designated Lyb-5  + B cells) are present at low 
frequencies in 2-wk-old fiormal mice and do not reach adult levels until ~3-4 wk of 
age (4). In both neonatal mice and mice with the xid defect, the failure to respond to 
polysaccharide  antigens  correlates  with  an  absence  or  diminished  number  of this 
mature subset of B cells (4). A requirement for Lyb-5  ÷ B cells in the in vitro antibody 
response  to  the  type  2  antigen,  trinitrophenylated-Ficoll  (TNP-FicolI)  has  been 
demonstrated (7). 
We have examined  the ability of IM6-KLH to stimulate production  of anti-Dex 
antibodies in neonatal mice and in mice with the xid defect. We report here that the 
production of anti-Dex antibodies in response to this TD analogue of Dex is deficient 
in both groups of mice and that in normal adult mice the production of an anti-Dex 
antibody response to IM6-KLH and  to IM6 Brucella  abortus  (IM6-BA)  requires  the 
presence  of  Lyb-5  +  B  cells.  These  results,  together  with  previous  studies  (8)  of 
unresponsiveness  to  phosphocholine  (PC)  conjugated  to  BA,  suggest  that  the  ex- 
presssed B cell repertoire is skewed such that the vast majority, if not all, of the B cells 
I Abbreviations used in this paper: BA, Brucella abortus; BSA, bovine serum albumin; C, complement; CFA, 
complete Freund's adjuvant; Dex, dextran; IM6, Isomaltohexaose;  KLH, keyhole  limpet hemocyanin; PC, 
phosphocholine; PFC, plaque-forming  cell; RIA, radioimmunoassay;  TD, thymus-dependent; TNP, trini- 
trophenyl. 
Journal of Experimental Medicine • Volume 157, February 1983  657-666  657 658  IMMUNE  RESPONSE TO THYMUS-DEPENDENT  B512 DEXTRAN 
capable of responding to carbohydrate determinants, whether presented as  type  1, 
type 2, or TD antigens, are in the Lyb-5  + subset. 
Materials and Methods 
Mice.  All mice were obtained from the Small Animal Section, Division of Research Services, 
National  Institutes of  Health,  or  The  Jackson  Laboratory,  Bar  Harbor,  ME,  and  were 
immunized at  12-16 wk of age unless otherwise indicated. (CBA/N ×  DBA/2)F1 male mice 
used as recipients in the adoptive transfer experiments were 6 mo old. 
Immunizations.  CBA/N,  CBA/CaHN,  and  various CBA/N  F1  mice were  given primary 
immunizations of 50  ~g  IM6-KLH  in complete  Freund's adjuvant  (CFA)  (H37Ra;  Difco 
Laboratories,  Detroit,  MI)  administered in the  hind footpads  (25  ~g)  and subcutaneously 
behind the neck (25/Lg). They were bled 3 wk after the primary immunization. Mice that were 
boosted were given 20/.tg IM6-KLH in incomplete Freund's adjuvant 4-8 wk after the previous 
immunization  and were bled 1 wk later. C57BL6/J mice used in the ontogeny experiment were 
immunized with 50 #g IM6-KLH in CFA given intraperitoneally, and were bled 4 wk after 
immunization. Mice used in the adoptive transfer experiments were immunized with 50 lttg of 
IM6-KLH or dinitrophenylated (DNP)-KLH in CFA given in the footpads and subcutaneously, 
and  1-2 mo later they were  boosted with  20/xg of IM6-KLH or DNP-KLH in phosphate- 
buffered saline given intraperitoneally. 1 wk after boosting, their spleens were  removed and 
processed  for donor cells. 
Antigens.  IM6-KLH was prepared as described previously (1). IM6-BA was prepared by the 
reaction of 30 /Lmol of the isothiocyanate derivative of IM6-phenethylamine and 0.2  ml of 
packed BA as described by Smith et al. (9). TNP-BA was prepared by the method described by 
Mond et al.  (10). DNP10-KLH was prepared by a modification of the method of Benacerraf 
and Levine (11). 
Anti-Lyb-5 Treatment.  Anti-Lyb-5 serum was prepared by immunization of C57BL/6 mice 
with DBA/2 spleen cells;  the serum was  rendered specific  by absorption with thymus and 
spleen cells from male (CBA/N X DBA/2)Fa mice,  as described by Ahmed et al.  (6). Spleen 
cells were  treated with anti-Lyb-5 antiserum and complement (C)  or with a  control serum 
(DBA/2 anti-C57BL/6 spleen cells) and C as described by Ahmed et al. (6). 
Plaque-Forming Cell (PFC) Assays.  Anti-Dex PFC were measured as described by Stein et al. 
(1). Anti-TNP PFC were measured by the method of Rittenberg and Pratt (12). 
Radioimmunoassay (RIA).  RIA analysis of anti-IM6 (assayed on IM6-bovine serum albumin 
[BSA]-coated plates)  and anti-Dex (assayed on Dex-coated plates)  antibodies was performed as 
described by Stein et  al.  (1). Titrations consisting of serial  threefold dilutions of sera were 
performed. Analyses for total IgG antibody and for antibody of IgG subclasses were carried out 
in the presence of 0.1 M 2-mercaptoethanol. 
Results 
Anti-Dex Response in xid Mice Immunized with IM6-KLH.  (CBA/N X DBA/2)F1 male 
mice, which express the xid-determined immune defect, were immunized and boosted 
with IM6-KLH. In Table I IgG anti-IM6 and anti-Dex titers of primary, secondary, 
and tertiary sera are compared to the primary response of normal F1 males derived 
from the reciprocal cross [i.e., (DBA/2 X CBA/N)F1 males]. Even after three immu- 
nizations, sera from the defective animals contained little if any IgG antibody capable 
of binding Dex, whereas substantial IgG1  anti-Dex titers and measurable IgG3 and 
IgG2b anti-Dex antibodies were observed in the sera of normal mice after a  single 
immunization with  IM6-KLH.  The  xid  mice  did  produce  some  IgG  anti-hapten 
antibody to IM6-KLH; this was mainly of the IgGl class and bound IM6-BSA, but 
only a small fraction of it cross-reacted with Dex. xid mice derived from another cross 
(CBA/N x  C57BL/6N) did produce anti-Dex antibody after secondary immunization 
(Table II). The anti-Dex titers of sera of F1 males from this cross were less than those STEIN  ET  AL. 
TABLE  I 
Response of (CBA/N ×  DBA/2) F1 Mice to IM6-KLH 
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lsotype of antibody 
IgG3  IgG1  IgG2b  IgG2a 
IM6-BSA*  Dex  IM6-BSA  Dex  IM&BSA  Dex  IM6-BSA  Dex 
(C×D)F1 (xid)  1°~  40  15  630  356  27  27  ~0  30 
20  40  0  5,700  350  210  160  500  50 
3 °  20  0  2,500  100  60  10  130  15 
(D ×  C)F1 (normal)  I °  3,000  1,500  40,000  14,000  729  1,000  110  115 
* Sera from (CBA/N ×  DBA/2N)F1  [((2 ×  D)F1] and (DBA/2N ×  CBA/N)F1  [(D ×  C)F1] male mice (10 
mice/group) were pooled and titrated  on IM6-BSA or Dex-coated microtiter plates and tested  with 3H- 
labeled anti-subclass  reagents.  Results here and in subsequent tables are reported  as the inverse  of the 
dilution of serum that binds 1% of the added ligand. Mice were bled 3 wk after the primary immunization 
and 1 wk after the secondary  and tertiary immunizations. 
1  °, primary;  2 °, secondary;  3 °, tertiary. 
TABLE  II 
Response of (CBA/N X  C57BL/IO)Fa Mice to IM6-KLH 
lsotype of antibody 
I~3  I~1  I~2b  I~2a'~  l~2a ~ 
IM6-BSA*  Dex  IM6-BSA  Dex  IM6-BSA  Dex  IM6-BSA  Dex  IM6-BSA  Dex 
(C ×  B)FI male 
Preimmune  0  0  0  0  200  2130  0  0  0  0 
2 ° anti-tM6-KLH  729  1,400  20,000  6,500  [,600  700  600  I75  1,200  1,20t3 
((2 ×  B)Fj female 
Preimmune  0  100  I00  18  100  1130  0  37  0  0 
2 ° anti-lM6-KLH  729  3,000  125,000  35,000  3,200  3,200  800  600  1,2(30  1,400 
* Sera from (CBA/N X C57BL/10)Ft [(C ×  B)FI] male and female mice were pooled and titrated on IM6-BSA or Dex-coated plates and tested 
with all-anti-subclass  reagents.  (See *, Table I). 
:~ lgG2a" and IgG2a  b allotypes were analyzed separately  using allotype-specillc  reagents. 
TABLE  III 
Response of CBA/N Mice to IM6-KLH 
Isotype of antibody 
IgM  IgG3  lgG I  IgG2b  lgG2a 
IM6-BSA*  Dex  IM6-BSA  Dex  IM6-B;SA  Dex  IM6-BSA  Dex  IM6-BSA  Dex 
CBA/N (xid) 
Prelmmune  25  25  10  0  12  0  I00  I00  38  20 
2 ° anti-lM6-KLH  600  550  2,200  2,200  6,500  3,000  6,600  2,200  24.000  6,600 
CBA/CaHN (normal) 
Preimmune  12,000  4,000  125  425  20  25  200  81  80  30 
2 ° anti-lM6-KLH  120,000  180,000  120,000  100,000  59,000  59,000  30,000  10,000  48,000  6,600 
CBA/CaHN 
Ratio---  200  327  55  45  9  20  5  5  2  1 
CbA/N 
* Sera from 10 mice/group  were pooled and tltrated on IM6-BSA or Dex-coated plates and assayed  with all-labeled anti-isotype sera (see *, 
Table 1.) 
of phenotypically  normal  females by a  factor of five for IgG 1, the most prevalent  IgG 
isotype  in  this  response,  and  showed  variable,  and  often  smaller,  differences  in  the 
other IgG isotypes.  However,  the tilers of IgG3, IgG2b,  and IgG2a anti-Dex  antibodies 
in the sera of IM6-immunized  normal F1 female mice of this cross were quite low. We 660  IMMUNE  RESPONSE  TO  THYMUS-DEPENDENT  B512  DEXTRAN 
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Fro,  I.  Antibody titers of pools of sera from  10-30 mice per group immunized at  various times 
after birth with either IM6-KLH (0) or Dex (O) and bled l  mo later. Titrations were performed on 
either IM6-BSA  (~)  or  Dex  (- -  -)  and isotypes were measured using "~H-labeled anti-subclass 
reagents. 
examined responsiveness to IM6-KLH of a third set of xid mice, CBA/N mice, using 
as  a  control  the  closely  related,  phenotypically  normal,  CBA/CaHN  strain.  The 
results of analysis of a secondary response to IM6-KLH are shown in Table III. The 
CBA/N mice developed measurable titers of anti-Dex but these were lower than those 
of CBA/CaHN by as  much as  300-fold,  depending on  the  isotype.  The  degree  of 
difference was greatest for those isotypes that were the most highly represented in the 
normal response, IgM, IgG3, and IgG1. We conclude from these experiments that a 
major defect exists  in the response ofxid mice to IM6-KLH. This defect is a markedly 
reduced capacity to produce antibodies  that  bind  Dex and  is  most  pronounced in 
those  isotypes  that  are  most  highly  represented  among  the  anti-Dex  antibodies 
produced by the normal, control strain in response to IM6-KLH. 
Response  to Dex and to IM6-KLH in Neonatal Mice.  C57BL/6J mice were immunized 
with Dex or with [M6-KLH at various ages from  1 d to  12 wk after birth. Sera from 
mice immunized at each time were pooled and tested for their ability to bind to IM6- 
BSA and to Dex-coated plates. As shown in Fig.  1, maximum anti-Dex antibody titers 
after immunization with Dex were not achieved until the mice were  12 wk old and 
the titers of IgG antibody raised against Dex were similar whether assayed on IM6- 
BSA or Dex. IgM antibodies raised against Dex in mice immunized at 6 wk of age or 
younger bound IM6-BSA substantially better than they bound Dex. The major IgG 
subclass in the anti-Dex response to Dex was IgG3; IgG1 and IgG2b titers were lower 
and no IgG2a was detected. 
Immunization with IM6-KLH at  1 d  of age produced substantial  anti-IM6 titers STEIN  ET  AL.  661 
of all isotypes. However, the anti-IM6 antibodies of young mice bound to IM6-BSA 
but  not  to  Dex.  The  anti-Dex  titers  among  IgM and  IgG antibodies  produced  in 
response  to IM6-KLH  rose  steadily  with  age.  The  IgM  anti-Dex  titers  achieved  a 
maximum at 6 wk of age. IgG1 and IgG3 anti-Dex titers reached plateaus at 3-4 wk 
of age, although the IgG3 anti-Dex titers of animals immunized at  12 wk of age with 
IM6-KLH were considerably higher than those immunized at 6 wk of age. In contrast, 
TABLE  IV 
Ratio of Anti-IM6 to Anti-Dex  Titers in Sera of Mice 
Immunized with IM6-KLH 
Isotype 
Age at immunization* 
1 d  l  wk  4  wk  12 wk 
IgG3  143  400  3  1.0 
IgGl  45  229  I  0.3 
IgG2b  1,000  247  9  1.0 
IgG2a  --~  --  --  -- 
* Data  taken  from  experiment  in  C57BL/6J  mice  shown  in  Fig.  1.  The 
numbers represent the ratio of the antibody titer obtained on IM6-BSA to 
that obtained on Dex. 
:~ --, Undefined, because the titers on Dex were all <10, the lowest dilution of 
serum tested. 
TABLE  V 
Effect of Anti-Lyb5  +  C on the Adoptive IM6-KLH Response 
Immunization 
Immunizing 
antigen 
Antigen at 
transfer 
Anti-Dex or TNP PFC*/spleen 
Antibody treatment 
Control serum +  C  Anti-Lyb-5 +  C 
Experiment 1 
Experiment 2 
Experiment 3 
Experiment 4 
IM6-KLH  IM6-KLH  6,227 X+ 
IM6-KLH  IM6 KLH  5,178 x+ 
DNP-KLH  DNP-KLH  2,412 X_: 
IM6-KLH  IM6-KLH  6,660 x+ 
IM6-KLH  IM6-BA§  1,800  X 
IM6-KLH  TNP-BA  480 _X 
No cells transferred[I  TNP-BA 
DNP-KLH  DNP-KLH  4,680 X+ 
IM6-KLH  IM6-KLH  1,840 X+ 
IM6-KLH  IM6-BA  680 +X 
No cells transferred  IM6-BA 
IM6-KLH  TNP-BA  2,340 
No cells transferred  TNP-BA 
DNP-KLH 
1.28 (5)$  <20  (5) 
1.33 (4)  <:20  (5) 
1.83 (5)  59o x 2.33 (4) 
1.18  (2)  200 ~  1.93  (3) 
1.81  (4)  120 X  1.07  (4) 
2.30 (6)  980 X: 2.34  (6) 
140 ~  1.31 (5) 
1.72 (6)  4,200 X 2.00  (5) 
1.27  (4)  <:20  (6) 
1.60 (4)  <20  (6) 
<20 (4) 
1.17 (7)  1,460 x  1.08  (2) 
<20 (4) 
3,480 X  1.10  (5)  DNP-KLH  3,120 ~  1.26 (5) 
* Indirect PFC, day 7 after transfer of 1 X  10  v cells. Geometric mean ~  relative SE. 
Parentheses indicate number of mice per group. 
§ Mice received 109 IM6-BA or TNP-BA. 
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TABLE VI 
Antibody Titers of Adoptive Transfer Recipients 
Antibody titers assayed on: 
Serum source  IM6-BSA  Dextran 
IgM  Total IgG  IgM  Total IgG 
Nonimmunized (D × C)F1 males* 
Immunized (D × C)Fl males 
Recipients of control serum +  C- 
treated cells~: 
Recipients  of  Anti-Lyb-5  +  C- 
treated cells 
1,800  55  800  729 
130,000  22,000  770,000  >10  ~ 
19,680  7,200  65,000  177,000 
0  30  0  500 
* All sera were pooled from four or five mice per group. (DBA/2 X CBA/N)FI [(D × C)F1] male 
normal serum was  obtained  from unimmunized mice. (D  X C)F1 male immune serum was 
obtained from the primed donor mice used in experiment 2, Table V at the time of killing. 
~c Animals were bled 7 d after adoptive transfer and challenge with IM6-KLH. Sera used in this 
experiment were pooled from the recipient mice from experiment 2, Table V. These pooled sera 
were titrated on IM6-BSA  or Dex-coated plates. 
the IgG2b anti-Dex titers continued to rise among animals immunized at  different 
times over the first  12 wk of life, and no IgG2a anti-Dex was detected in the sera of 
such mice. The changing pattern of specificity among the IgG subclasses of anti-IM6 
antibodies from mice immunized at different times during the first  12 wk of life can 
be appreciated by comparing the ratios of antibody titers measured on IM6-BSA to 
those on Dex  (Table IV). The ratios vary between 45  (IgG1)  and  1,000  (IgG2b)  in 
sera from mice immunized on the first day of life but approach a value of 1 as the age 
at immunization reaches  12 wk. 
Effect of Anti-Lyb-5 and C Treatment on the Response to IM6-KLH.  To assess the role of 
Lyb-5  + lymphocytes in the production of anti-IM6 antibodies that bind Dex, adoptive 
transfer experiments were performed in which spleen cells from phenotypically normal 
(DBA/2N X CBA/N)Fa male mice, primed and boosted with IM6-KLH, were treated 
with anti-Lyb-5 plus C  or a  control serum plus C  and then transferred with antigen 
to previously irradiated  (CBA/N  X  DBA/2N)F1  male mice. This treatment should 
eliminate Lyb-5  + B cells and thus allow a determination of the role of Lyb-5- cells in 
the production of anti-Dex antibodies. As a  control for  the response of the  Lyb-5- 
cells to IM6-KLH, DNP-KLH, TNP-BA, and IM6-BA were used as  antigens. The 
results  of  four  experiments  (Table  V)  indicate  that  anti-Lyb-5 plus  C  treatment 
completely eliminated the ability of IM6-KLH-primed cells to transfer an anti-Dex 
PFC response to recipients challenged with IM6-KLH or IM6-BA. When cells from 
donors  primed  to  DNP-KLH  were  similarly treated  and  tested  for  the  ability to 
transfer  an  anti-DNP  PFC  response  to  DNP-KLH  challenge,  anti-Lyb-5 plus  C 
treatment had no effect  (experiments 3  and 4)  or diminished but did not eliminate 
the  response  (experiment  2).  To  demonstrate  that  Lyb-5-  cells  from  IM6-KLH- 
primed animals could respond to  some  antigen, recipients of such cells received  a 
primary immunization with TNP-BA (experiments 3 and 4). In both experiments a 
substantial number of TNP PFC were observed in recipients. The anti-TNP PFC are 
less than maximal because the response was measured on day 7 after transfer, which 
is optimal for IM6-KLH or DNP-KLH but not for TNP-BA and because only indirect STEIN  ET  AL.  663 
PFC were measured. However, the responses obtained are considerably greater than 
those of irradiated  (CBA/N ×  DBA/2)F1 males, which received no cells. 
These  experiments  demonstrate  that  the  production  of anti-Dex  antibodies  in 
response  to  IM6-KLH  is  dependent  on  the  presence  of Lyb°5  +  lymphocytes.  As 
virtually all of the anti-IM6 antibodies stimulated by IM6-KLH in adult mice cross- 
react with Dex (1), it is expected that both the anti-IM6 and the anti-Dex responses 
to IM6-KLH would be eliminated by anti-Lyb-5 plus C, i.e., that there would be no 
residual antibodies that bound IM6-BSA but not Dex. The prediction is confirmed in 
an experiment in which recipients of IM6-KLH primed cells treated with anti-Lyb-5 
plus C  produced no anti-IM6 antibodies upon challenge with IM6-KLH (Table VI). 
This experiment also demonstrates that  the production  of both IgM and IgG anti- 
Dex antibodies are dependent upon Lyb-5  + cells in adult mice. 
Discussion 
We have examined the anti-Dex response in xid mice and in neonatal normal mice 
using the  thymus-dependent  analogue of B512  Dex,  IM6-KLH. Mice with  the xid 
defect produce very low levels of anti-Dex antibodies in response to IM6-KLH, even 
after boosting.  This is in  marked contrast  to immunization  of xid mice with  DNP- 
KLH, which  stimulates  a  very good anti-DNP  response (13).  These results suggest 
that the response to IM6-KLH, like the response to Dex itself, requires the presence 
of Lyb-5  + lymphocytes, which are lacking in xid mice. To examine this more carefully, 
we studied the ontogeny of the anti-Dex response using IM6-KLH as an immunogen. 
Although  the total response to the IM6-hapten reaches adult levels in animals  1 wk 
old,  anti-IM6  antibodies  that  cross-react  with  Dex  are  produced  in  substantial 
amounts  only in  animals  immunized  after the  age of 3-4  wk.  The  kinetics  of the 
development  of the  anti-Dex  component  of the  response are  very similar  to  those 
reported for the development of the response to TNP-Ficoll (4) and to the capacity of 
normal B cells to proliferate in response to anti-p stimulation (14), both of which have 
been shown to require Lyb-5  + lymphocytes. It has been reported that few cells bearing 
the Lyb-3 (5)  and Lyb-5 (6)  markers are present before 2 wk of age, and that adult 
frequencies  are  reached  at  4  wk  of age.  The  data  reported  here  show  that  the 
development of the cross-reactive anti-Dex response to IM6-KLH coincides with the 
reported  development of Lyb-5  + lymphocytes. Once the Lyb-5  + cells reach mature 
levels, at 4 wk of age, IM6-KLH stimulates anti-Dex antibodies at levels equivalent 
to adult responses. That IM6-KLH stimulates a  maximum anti-Dex response earlier 
in ontogeny than Dex itself is an interesting, but unexplained, observation. 
The  dependence  of the  IM6-KLH response on  the presence of Lyb-5  + cells was 
tested directly in adoptive transfer experiments using cells from adult  animals that 
had been primed with IM6-KLH and treated with anti-Lyb-5 plus C before transfer. 
The  experiments  demonstrate  that  the  adult  antibody  response  to  IM6-KLH  is 
eliminated  by  anti-Lyb-5  plus  C.  Moreover,  the  cells  remaining  after  immune 
elimination  with  anti-Lyb-5  were not  capable of responding  to  IM6-BA but  were 
capable of responding to DNP-KLH and TNP-BA. Our interpretation of these results 
is that the expressed repertoire of adult B cells is skewed such that the great majority 
of the activatable precursors of anti-Dex antibody-secreting cells are in  the Lyb-5  + 
subpopulation.  There are several possible explanations for this skewing. The first of 
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Lyb-5- cells because the genes for V  regions capable of binding such polysaccharides 
are not expressed in these cells. This would imply that unresponsiveness in xid mice to 
polysaccharides and to their nitrophenyl conjugates (e.g., TNP-Ficoll) are independent 
defects.  We  think  this  unlikely.  A  second  possibility  is  that  among  Lyb-5- ceils, 
precursors with receptors for polysaccharides do appear just as they do among Lyb-5  + 
B cells. Environmental polysaccharides fail, however, to activate these cells, whereas 
cells with receptors for nonpolysaccharide antigens  (e.g., proteins) are expanded due 
to environmental immunization. Thus, polysaccharide-specific B cells would become 
a  diminishing fraction of Lyb-5- cells.  A  third  possibility is that  Lyb-5- cells with 
receptors for carbohydrates are tolerized after encounter with environmental polysac- 
charides, thereby actively deleting precursors of anti-polysaccharide antibody-secret- 
ing  cells  from  the  Lyb-5- subset.  In  contrast,  Lyb-5  +  cells,  when  they  appear  in 
development,  may  be  expanded  after  exposure  to  environmental  polysaccharides. 
This would lead to the overwhelming majority of polysaccharide-reactive cells being 
in the Lyb-5  + subset. 
The question of whether or not neonatal  Lyb-5- cells are susceptible to tolerance 
induction by soluble polysaccharides has not been conclusively answered. Two reports 
of attempts to tolerize neonatal  cells to type 2  antigens  indicate  that  Lyb-5- cells, 
soon after birth, could not be tolerized to Dex or bacterial levan (15) or to TNP-Ficoll 
(16).  If Lyb-5- cells  are  indeed  not  tolerized  by environmental  antigens,  then  our 
data suggest that they are not capable of responding to them. Lyb-5- ceils from xid 
mice, on  the other  hand,  have been  reported  to  be more easily subject  to antigen 
blockade by TNP-Ficoll (17)  than normal adult B cells. 
The ability of some xid mice to make small amounts of anti-Dex antibodies would 
suggest either that xid mice may have a small number of Lyb-5  + B cells or that some 
Lyb-5-  B  cells  can  respond  to  Dex  determinants.  Similarly,  xid  mice  have  been 
reported to make anti-PC antibodies to some PC-containing antigens (18-21). In view 
of the finding that young adult xid mice make no anti-TNP antibody in response to 
TNP-FicoI1, we believe that the "leakiness" in the anti-Dex response is more likely to 
represent a meager response by Lyb-5- cells rather than the presence of small numbers 
of normal  Lyb-5  +  cells.  The  presence  of small  numbers  of defective  Lyb-5  +  cells, 
capable of responding to TD forms of polysaccharides but incapable of being triggered 
by environmental polysaccharides, would also be compatible with our findings. 
Summary 
Studies of the ontogeny of the immune response to B512 dextran  (Dex) show that 
antibody responses equal to those of adult mice are not attained until  12 wk of age. 
We have examined the anti-Dex response after immunization with a thymus-depend- 
ent  antigen  isomaltohexaosyl-keyhole  limpet  hemocyanin  (IM6-KLH)  and  have 
shown  that  the  development  of the  cross-reacting  anti-Dex  response  parallels  the 
development of Lyb-5  + B cells. Adult levels of anti-Dex antibody after immunization 
with  IM6-KLH are  achieved  in  mice between  3  and  12  wk of age,  a  time when 
Lyb-5  + cells have reached adult levels. Neonatal mice, immunized at 1 d or 1 wk after 
birth,  failed to produce a  significant amount of anti-Dex antibodies,  although  they 
did produce IM6-specific antibodies after immunization with IM6-KLH. Data, which 
support the conclusion from these experiments that Lyb-5  + cells are required  for an 
anti-polysaccharide response even when the immunizing antigen is thymus-dependent, STEIN ET  AL.  665 
include the failure of IM6-KLH  to stimulate a normal anti-Dex response in mice with 
the xid defect and the direct demonstration in normal adult mice that elimination of 
Lyb-5  + cells from spleens of mice primed with IM6-KLH  abolishes the ability of these 
cells  to  transfer  an  anti-Dex  response.  The  data  imply  that  the  expressed  B  cell 
repertoire in adult animals is skewed such that the vast majority of B cells capable of 
responding to polysaccharide determinants are in the Lyb-5  + subset. 
Received  for publication 26July 1982 and in revised  form 13 September 1982. 
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